| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.9 |
| mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |